惠斯安普HRA品牌怎么样 申请店铺

我要投票 惠斯安普HRA在医疗器械行业中的票数:725 更新时间:2026-01-26
惠斯安普HRA是哪个国家的品牌?「惠斯安普HRA」是 秦皇岛市惠斯安普医学系统股份有限公司 旗下著名品牌。该品牌发源于河北省秦皇岛市,由创始人陈董在2011年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力惠斯安普HRA品牌出海!将品牌入驻外推网,定制惠斯安普HRA品牌推广信息,可以显著提高惠斯安普HRA产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

惠斯安普HRA怎么样

秦皇岛市惠斯安普医学系统股份有限公司,成立于2011年,是一家专注于生物医学领域医疗设备及系统的设计、开发、生产及销售为一体的企业。公司拥有生物医学领域的博士、硕士专业研发人才50余名;与国内外多家生物医学研究机构、高等院校和医院建立了稳定的合作关系,并设有电磁干扰与静电防护院士工作站、生物医学研究中心和生物医学体验中心。

惠斯安普医学系统股份有限公司紧密围绕国家“战略前移,重心下移”的人口与健康科技发展战略方针,努力在国民健康管理产业发展中开拓自己的成长空间,先后研制成功HRA疾病早期筛查及健康风险评估、ADDS阿尔茨海默病早期筛查及诊断、ADTS记忆力障碍训练系统、PMR脉冲磁共振微循环修复等“全链式”健康管理适宜技术设备,构建了覆盖“医院前“和”医院后”细分市场的疾病早期筛查评估、健康风险干预、功能康复全产品线。

目前,惠斯安普产品用户已遍及国内32个省、市、区。惠斯安普医学系统股份有限公司已与中国健康促进基金会、清华大学、北京大学结成战略合作伙伴关系,在国内联合开展以HRA应用研究和国民健康云数据计划为核心内容的健康管理工程,加速了HRA在国家健康管理示范基地及其旗舰单位、高校和体育运动系统的推广,使更广大的人群从中受益。

发展历程:

2011年

4月 惠斯安普医学公司正式成立;

7月 受邀参展由国家科技部参加了国家十一五重大科技成果展;

2013年

5月 HRA健康风险评估设备取得中华人民共和国医疗器械注册证;

7月 HRA健康风险评估设备参加澳门科技周活动;

2014年

4月 惠斯安普公司与清华大学联合发起的国民“健康云数据”计划正式启动;

11月 中国高校师生健康促进联盟在京成立,HRA成为国内高校师生健康数据釆集专用设备;

2015年

3月 惠斯安普成为中国人民解放军总后勤部物资采购供应商;

4月 惠斯安普与中国健康促进基金会合作的“HRA多中心应用研究项目”正式启动;

2016年

8月 惠斯安普公司正式挂牌新三板,股票代码838857;

2017年

1月 HRA健康风险评估快速体检车在秦皇岛惠斯安普下线;

9月 惠斯安普获批成立省级科技专家企业工作站;

2018年

10月 惠斯安普与阿里健康签署战略合作协议,共同开启“应用人工智能黑科技HRA,开展区域人群健康风险评估管理”计划。


Qinhuangdao Huisi Anpu Medical System Co., Ltd., founded in 2011, is an enterprise focusing on the design, development, production and sales of medical equipment and systems in the biomedical field. The company has more than 50 doctoral and master's R & D talents in biomedical field. It has established stable cooperation with many biomedical research institutions, colleges and hospitals at home and abroad, and has academician workstation for electromagnetic interference and electrostatic protection, biomedical research center and biomedical experience center. Based on the national strategy of population and health science and technology development, wisanpu Medical System Co., Ltd. strives to develop its own growth space in the development of national health management industry. It has successively developed the Department of early screening and health risk assessment of HRA disease, early screening and diagnosis of Alzheimer's disease, and training of ADTs memory impairment The "whole chain" health management appropriate technology and equipment, such as unifying and PMR pulse magnetic resonance microcirculation repair, has constructed the whole product line of disease early screening assessment, health risk intervention and functional rehabilitation covering the "pre hospital" and "post hospital" market segments. At present, the products of wisanp have been used in 32 provinces, cities and districts in China. Wisanpu Medical System Co., Ltd. has formed strategic partnership with China health promotion foundation, Tsinghua University and Peking University to jointly carry out the health management project with HRA application research and national health cloud data plan as the core content in China, accelerating the promotion of HRA in the national health management demonstration base and its flagship units, universities and sports systems To benefit the wider population. Development history: in April 2011, wisanp medical company was officially established; in July, it was invited to participate in the national 11th five year major scientific and technological achievements exhibition by the Ministry of science and technology of the people's Republic of China; in May 2013, HRA health risk assessment equipment obtained the registration certificate of medical devices of the people's Republic of China; in July, HRA health risk assessment equipment participated in Macao science and technology week; in April 2014, wisanp medical company and Tsinghua University jointly participated The national "health cloud data" plan launched officially; in November, the health promotion alliance of teachers and students of Chinese universities was established in Beijing, HRA has become a special equipment for health data collection of teachers and students in Colleges and universities in China; in March 2015, Huis amp became a material procurement supplier of the General Logistics Department of the people's Liberation Army; in April, the "HRA multi center application research project" cooperated by Huis amp and China health promotion foundation was officially launched; in August 2016, Huis amp officially launched the new third board, Stock Code: 838857; in January 2017, the HRA health risk assessment rapid physical examination vehicle was offline in Huisi Anpu, Qinhuangdao; in September, Huisi Anpu was approved to establish a provincial science and technology expert enterprise workstation; in October 2018, Huisi Anpu and Ali health signed a strategic cooperation agreement to jointly launch the plan of "applying human industry intelligent black technology HRA to carry out regional population health risk assessment management".

本文链接: https://brand.waitui.com/1b66b8b94.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

锋龙股份:将就股票交易波动情况进行停牌核查

36氪获悉,锋龙股份公告,因股票自2025年12月25日至2026年1月23日已连续17个交易日涨停,价格涨幅为405.74%,期间多次触及股票交易异常波动情形,公司股票短期内价格涨幅较大,已累积巨大交易风险,明显偏离市场走势,未来可能存在股价快速下跌的风险。为维护投资者利益,公司将就股票交易波动情况进行停牌核查。公司股票自2026年1月26日(星期一)开市起停牌,自核查结束并披露核查公告后复牌,预计停牌时间不超过5个交易日。

2小时前

“木头姐”:特斯拉的竞争优势在于其成本将比其他竞争对手低至少50%

“木头姐”凯西・伍德谈特斯拉Robotaxi,称目前正处于自动驾驶出租车市场兴起的初期阶段。根据她们团队的测算,特斯拉的竞争优势在于其成本将比其他竞争对手低至少50%。(财联社)

2小时前

嘉美包装:将就股票交易波动情况进行停牌核查

36氪获悉,嘉美包装公告,公司股票自2025年12月17日至2026年1月23日期间价格涨幅为408.11%,期间多次触及股票交易异常波动情形,公司股票短期内价格涨幅较大,已背离公司基本面,为维护投资者利益,公司将就股票交易波动情况进行停牌核查。公司股票自2026年1月26日(星期一)开市起停牌,预计停牌时间不超过5个交易日。

2小时前

上海沪工:股东明鑫光储拟减持不超3%公司股份

36氪获悉,上海沪工公告,公司持股5%以上股东上海明鑫光储企业管理有限公司因自身资金需求,计划自公告披露之日起15个交易日后的3个月内,通过集中竞价和大宗交易方式合计减持公司股份不超过1010.72万股,即不超过公司总股本的3%。其中,通过集中竞价减持不超过336.91万股,通过大宗交易减持不超过673.81万股。本次减持不设价格区间。

2小时前

东吴证券:基金四季报,透露了哪些重要线索?

36氪获悉,东吴证券发布研究报告称,截至1月22日,公募基金四季报已披露完毕。从市场主线来看,进入1月下旬后,年报业绩预告将进入密集披露期,市场主线将聚焦业绩线。东吴证券挖掘背后资金逻辑,提炼出四条核心线索,为后续大势研判与板块配置提供指引。

2小时前

本页详细列出关于惠斯安普HRA的品牌信息,含品牌所属公司介绍,惠斯安普HRA所处行业的品牌地位及优势。
咨询